Contents

Current Cancer Drug Targets, Volume 14 - Number 8

Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3

, 14(8): 685 - 699

You P. Wang, Sha Yi, Lu Wen, Ben P. Zhang, Zichu Zhao, Jing Y. Hu, Fei Zhao, Jing He, Jun Fang, Chun Zhang, Guohui Cui and Yan Chen


DOI: 10.2174/1568009614666141028123835



AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1

, 14(8): 700 - 712

Alexandra Schrader, Wagma Popal, Nils Lilienthal, Giuliano Crispatzu, Petra Mayer, Dan Jones, Michael Hallek and Marco Herling


DOI: 10.2174/1568009614666141028101711




Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy

, 14(8): 727 - 736

Kaniyampadi S. Snima, Prathesha Pillai, Aleena M. Cherian, Shantikumar V. Nair and Vinoth-Kumar Lakshmanan


DOI: 10.2174/1568009614666141020105502



MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review

, 14(8): 737 - 751

Hamidreza Maroof, Ali Salajegheh, Robert A. Smith and Alfred K.-Y. Lam


DOI: 10.2174/1568009614666141020100337



Bioactive Albumin-Based Carriers for Tumour Chemotherapy

, 14(8): 752 - 763

Yasser Shahzad, Ikram U. Khan, Talib Hussain, Alamgeer, Christophe A. Serra, Syed A.A. Rizvi, Minja Gerber and Jeanetta du Pless


DOI: 10.2174/1568009614666141028100640



Zebrafish: Predictive Model for Targeted Cancer Therapeutics from Nature

, 14(8): 764 - 773

Nursafwana S. Zulkhernain, Soo H. Teo, Vyomesh Patel and Pei J. Tan


DOI: 10.2174/1568009614666141028121347




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science